Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants
NCT05133050
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
510
Enrollment
OTHER
Sponsor class
Conditions
Alport Syndrome
Interventions
DRUG:
Ramipril
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine